Executive Summary
On January 8, 2026, an unprecedented surge of 84 US SEC 8-K filings reveals a confluence of executive transitions (over 40 instances, mostly neutral), material definitive agreements (25+ cases signaling potential M&A or partnerships), and pockets of distress including delistings, impairments, and agreement terminations. While the majority carry neutral sentiment and medium materiality, cross-filing patterns indicate heightened small-cap and biotech activity amid leadership churn, with limited systemic sector contagion but elevated uncertainty from undisclosed details. Portfolio managers should prioritize M&A catalysts for alpha while hedging delisting and impairment risks, as cumulative volume suggests a pivotal market event day.
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from January 06, 2026.
Investment Signals(5)
- ▲
Surge in Material Definitive Agreements (Item 1.01) across 25+ filings including Curis, Crown Electrokinetics, Century Therapeutics, and SPACs like Aquaron Acquisition [BULLISH] - Potential M&A/takeover wave creating upside in biotech and small caps
- ▲
Multiple officer appointments/promotions in established firms like Walmart, Teleflex, and LPL Financial [BULLISH] - Signals stable succession planning amid churn
- ▲
Delistings at SRx Health Solutions and urban-gro [BEARISH] - Liquidity erosion and valuation cliffs imminent
- ▲
Material impairments and exit costs at HNI Corp and ImmuCell [BEARISH] - Restructuring signals operational distress
- ▲
Agreement terminations at Sky Quarry, Alaunos Therapeutics, Neuphoria [BEARISH] - Disrupted strategies and potential revenue gaps
Risk Flags(4)
- ▼
Widespread undisclosed details in high-materiality filings (e.g., no parties/values in 1.01/2.03 events), amplifying uncertainty and potential for negative surprises across small caps/biotech
- ▼
Delisting notices (SRx #28, urban-gro #69) and administration (#70) indicating acute liquidity crises in micro-caps
- ▼
Cluster of equity dilutions (Item 3.02 in 10+ filings like Beneficient, Canopy Growth) risking shareholder value erosion
- ▼
Elevated officer churn (40+ filings) potentially signaling underlying governance instability or performance issues
Opportunities(4)
- ◆
Probe Item 1.01 filings (e.g., KALA Bio, Williams Companies, American Well) for undisclosed M&A/partnerships offering takeover premiums in biotech/energy
- ◆
Long stable leadership transitions in large caps (Walmart, Illumina) while shorting high-churn small caps for relative outperformance
- ◆
Event-driven alpha from SPAC de-SPAC activity (T-REX, Aquaron, Art Technology) if full filings reveal accretive targets
- ◆
Distressed asset plays post-impairments/exits (HNI, ImmuCell) for post-restructuring rebounds
Sector Themes(3)
- Biotech/therapeutics frenzy◆
15+ filings (Curis, Spruce Biosciences, Alaunos, Tango, Agenus, Indaptus) with agreements/terminations/dilutions signaling pipeline deals amid funding pressures
- ◆
Ubiquitous executive churn across all sizes (Walmart to micro-caps), hinting at post-2025 talent shifts or performance resets without clear sector causality
- ◆
Small-cap distress markers (delistings, impairments, admin) concentrated in health/tech (SRx, urban-gro, ImmuCell), contrasting neutral M&A in SPACs/realty
Watch List(4)
- 👁
SRx Health Solutions & urban-gro - Delisting trajectories demand immediate short/avoid positions; monitor trading halts
- 👁
HNI Corp & ImmuCell - Impairment/exit costs could cascade into earnings misses; track Q4 guidance
- 👁
Biotech cluster (Century Therapeutics, Canopy Growth, Alaunos) - Multi-item filings (1.01+3.02) for dilution/M&A details unlocking catalysts
- 👁
SPACs (T-REX Acquisition, Aquaron, Art Technology) - Merger progress amid high volume; alpha if targets emerge
Filing Analyses(84)
08-01-2026
T-REX Acquisition Corp. filed an 8-K on 2026-01-08 (AccNo: 0001477932-26-000088, Size: 136 KB) disclosing a Merger/Acquisition under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.
08-01-2026
Terreno Realty Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006930), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the transaction, parties, dollar values, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
08-01-2026
Curis Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001108205-26-000002, Size: 1 MB), reporting events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no transaction values, share counts, financial metrics, named parties, or other quantitative details disclosed in the provided information.
08-01-2026
Enpro Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000570, Size: 139 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or quantitative data are provided in the summary. Sector is not specified.
08-01-2026
Neuphoria Therapeutics Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002245, size 293 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a material definitive agreement, with financial statements and exhibits under Item 9.01. No details on the agreements, parties, values, or impacts are disclosed. This is a multi-item mandatory filing as a material event.
08-01-2026
Crown Electrokinetics Corp. filed an 8-K on 2026-01-08 (AccNo: 0001213900-26-002308, Size: 231 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement and Item 2.01 Completion of Acquisition or Disposition of Assets. Item 9.01 provides Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, consideration, or financial metrics are disclosed.
08-01-2026
Catheter Precision, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000839, Size: 287 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or other terms are disclosed.
08-01-2026
TELEFLEX INC filed a Form 8-K on January 08, 2026 (AccNo: 0000096943-26-000003, Size: 192 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also covers Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, reason, financial metrics, or quantitative data are provided.
08-01-2026
Company filed an 8-K on 2026-01-08 (AccNo: 0001140361-26-000614, Size: 215 KB) reporting an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Event Type: Officer Change. No specific details on officers, reasons, or impacts disclosed.
08-01-2026
Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Century Therapeutics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001952, Size: 7 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. Sector is not specified.
08-01-2026
Spruce Biosciences, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007038, Size: 1 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector not specified.
08-01-2026
Limitless X Holdings Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000895), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction values, share counts, dollar amounts, or named entities beyond the filer disclosed. Sector is not specified.
08-01-2026
Beneficient filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000893, Size: 10 MB) as a multi-item disclosure covering Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, share counts, or other quantitative metrics are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing related to equity transactions and corporate governance changes.
08-01-2026
Frontier Group Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007030, Size: 170 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or share counts are mentioned.
08-01-2026
Walmart Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000104169-26-000008, Size: 258 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Sector is not specified.
08-01-2026
CorMedix Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002350, Size: 297 KB), reporting an Officer Change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position, reason for change, or financial metrics are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Lightwave Logic, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001079973-26-000061, Size: 194 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed in the provided summary. Sector is not specified.
08-01-2026
Leslie's, Inc. disclosed an Item 5.02 event in an 8-K filing on January 8, 2026 (AccNo: 0001193125-26-007067, Size: 183 KB), related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Alaunos Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007054, Size: 580 KB), reporting under Item 1.02 termination of a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the events, transaction values, or financial impacts are provided in the summary. Sector is not specified.
08-01-2026
Xilio Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007063, size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). Event dated January 08, 2026; sector not specified. No specific details on officer position, appointment/resignation, reasons, or financial metrics provided.
08-01-2026
LPL Financial Holdings Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007083, Size: 166 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, reason for change, or any quantitative data are disclosed.
08-01-2026
Nuvve Holding Corp. disclosed an officer change event via Form 8-K filed on January 08, 2026 (AccNo: 0001836875-26-000008, Size: 203 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
08-01-2026
USANA Health Sciences Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0000896264-26-000002, size 176 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided. Sector is not specified.
08-01-2026
Tango Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001193125-26-007086, Size: 5 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is classified as an Officer Change event. No specific details on officers, reasons for change, financial metrics, or quantitative data are disclosed in the provided filing summary.
08-01-2026
Sky Quarry Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001096906-26-000041), reporting under Item 1.02 the termination of a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, value, terms, or financial impact are disclosed. This represents a potentially negative event as it involves termination of something deemed material by the company.
08-01-2026
First Northwest Bancorp filed a Form 8-K on January 08, 2026 (AccNo: 0001437749-26-000851, Size: 152 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected individuals, positions, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
SRx Health Solutions, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000926, size: 229 KB) under Item 3.01 reporting a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial details, transaction values, reasons for delisting, or other impacts are disclosed. Sector is not specified.
08-01-2026
Apple iSports Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000095, Size: 128 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, names, reasons for change, or quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
HNI CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000697, Size: 207 KB), reporting Item 2.05 Costs Associated with Exit or Disposal Activities, Item 2.06 Material Impairments, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of potentially negative events involving restructuring costs and asset impairments. No specific dollar values, transaction sizes, or quantitative financial impacts are disclosed.
08-01-2026
Company filed Form 8-K on 2026-01-08 (AccNo: 0000944130-26-000004, Size: 185 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change with event date January 08, 2026. No specific details on position affected, individual names, reasons for change, internal/external status, compensation, or quantitative metrics are disclosed.
08-01-2026
Netcapital Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000969, Size: 16 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or other quantitative data disclosed in the provided summary. Sector not specified.
08-01-2026
KALA BIO, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001829126-26-000110, Size: 526 KB) disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are provided in the summary.
08-01-2026
Ambiq Micro, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007673, Size: 143 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, compensation, or board impacts are provided. Sector is not specified.
08-01-2026
TruBridge, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007672), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or exhibits provided in the summary. All transaction values, financial metrics, and named entities beyond the filer are NOT_DISCLOSED.
08-01-2026
TRANSUITE.ORG INC. disclosed an officer change via Form 8-K filed on January 8, 2026 (AccNo: 0001640334-26-000058, Size: 126 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data provided in the filing summary. Sector not specified.
08-01-2026
Anika Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007655, Size: 557 KB) reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or names are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Williams Companies, Inc. filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007722, Size: 371 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.
08-01-2026
Company filed Form 8-K on 2026-01-08 (AccNo: 0001140361-26-000721, Size: 846 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 includes Financial Statements and Exhibits. No details on transaction parties, value, terms, or impacts are disclosed in the provided information.
08-01-2026
Agenus Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007706, Size: 142 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.03 Material Modifications to Rights of Security Holders. No details on the agreement, transaction terms, parties involved, financial values, or specific modifications are disclosed in the provided information. Sector not specified.
08-01-2026
Alliant Energy Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000352541-26-000003, Size: 193 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or quantitative data are provided in the available information. Event type is Officer Change; sector not specified.
08-01-2026
Canopy Growth Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002134, Size: 2 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant transaction involving agreements, financing, and equity issuance, but core event details, transaction values, share counts, and financial impacts are NOT_DISCLOSED. No specific numbers, named counterparties, or strategic context are provided in the summary.
08-01-2026
CEMTREX INC filed an 8-K on 2026-01-08 (AccNo: 0001493152-26-000973, Size: 247 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on transaction parties, structure, value, or terms are provided in the filing summary. Sector not specified.
08-01-2026
Acushnet Holdings Corp. filed a Form 8-K on 2026-01-08 (AccNo: 0001672013-26-000007, Size: 501 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, parties, terms, value, or financial impacts are disclosed. This is a multi-item filing for a Material Event from US SEC source; sector not specified.
08-01-2026
Aquaron Acquisition Corp. filed an 8-K on January 8, 2026 (AccNo: 0001213900-26-002528, Size: 183 KB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 the creation of a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement, in connection with a Merger/Acquisition event. No specific details on parties involved, deal structure, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.
08-01-2026
Applied Digital Corp. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000974, Size: 371 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation status, reasons, or compensation are provided. Sector is not specified.
08-01-2026
Littelfuse Inc./DE filed an 8-K on January 8, 2026 (AccNo: 0001140361-26-000720, size 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reason, or compensation provided in the available information. Sector not specified.
08-01-2026
ImmuCell Corp /DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000885, Size: 217 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 2.06 (Material Impairments), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing material impairments alongside financial results and other events. Specific details including dollar values, transaction sizes, financial metrics, or strategic context are NOT_DISCLOSED.
08-01-2026
Graphic Packaging Holding Co filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007697, Size: 132 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the officer's name, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
The company filed a Form 8-K on January 8, 2026 (AccNo: 0001331754-26-000004, Size: 201 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, appointment/resignation status, or any quantitative financial metrics are provided. Sector is not specified.
08-01-2026
EPLUS INC filed a Form 8-K on January 08, 2026 (AccNo: 0001022408-26-000009, Size: 168 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided. Sector is not specified.
08-01-2026
Senmiao Technology Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002536, Size: 267 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or compensation provided.
08-01-2026
MID PENN BANCORP INC disclosed an officer change via Form 8-K filed on January 08, 2026 (AccNo: 0000879635-26-000007, Size: 494 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change, reasons, or compensation are provided.
08-01-2026
Vita Coco Company, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001348, Size: 198 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or any quantitative data are disclosed in the provided filing summary.
08-01-2026
V2X, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001359, Size: 181 KB), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
Company filed Form 8-K on 2026-01-08 (AccNo: 0001168165-26-000005, Size: 21 MB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a material event. No transaction details, values, counterparties, or financial metrics are disclosed.
08-01-2026
Calumet, Inc. (/DE) filed Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007783, size: 410 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing from the US SEC source. No specific details, transaction values, or financial metrics disclosed in the provided summary.
08-01-2026
BION ENVIRONMENTAL TECHNOLOGIES INC filed a Form 8-K on January 08, 2026 (AccNo: 0001079973-26-000065, Size: 182 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, financial terms, or exhibits are disclosed in the provided summary. Sector not specified.
08-01-2026
MERIT MEDICAL SYSTEMS INC filed an 8-K on January 08, 2026 (AccNo: 0000856982-26-000002, Size: 292 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Event type is Officer Change from US SEC source; sector not specified. No specific details on position, person, reason, or financial metrics provided.
08-01-2026
VEEA INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002557, Size: 250 KB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the transactions, counterparties, or values disclosed in the provided information. Sector is not specified.
08-01-2026
McGraw Hill, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007781, size: 131 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details such as names, positions, reasons for change, or quantitative data are provided in the summary. Sector is not specified.
08-01-2026
SilverBox Corp V filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002148, size: 261 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, positions affected, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Art Technology Acquisition Corp. filed an 8-K on January 8, 2026 (AccNo: 0001213900-26-002553, Size: 1 MB) disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing indicates a merger/acquisition event for the SPAC-like entity, but specific parties, deal structure, valuation, and terms are NOT_DISCLOSED. Sector not specified.
08-01-2026
Beachbody Company, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007774, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, disclosures, transaction value, or financial impacts are provided in the available summary. All quantitative financial data is NOT_DISCLOSED.
08-01-2026
Loop Industries, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000892, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data are disclosed. Sector is not specified.
08-01-2026
Quanterix Corp filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001369, Size: 350 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.
08-01-2026
urban-gro, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001213900-26-002552, Size: 194 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting trigger, financial impacts, transaction values, or sector are disclosed. This represents a material compliance event with bearish implications for liquidity and valuation.
08-01-2026
Company entered Administration on January 08, 2026, as per ASX announcement, with a summary statement regarding Glencore plc; ASX code and sector not disclosed. This indicates voluntary administration under Corporations Act 2001 (s436A), likely creditor-initiated or director-appointed, but secured vs unsecured creditor details, asset values, debt obligations, and recovery prospects are NOT_DISCLOSED. Stakeholder impacts including employee entitlements, supplier exposures, director liabilities, and shareholder wipeout cannot be assessed due to missing critical data; recovery outlook poor absent further disclosures.
08-01-2026
Planet 13 Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000891, Size: 150 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any compensation arrangements are provided in the filing summary. Sector is not specified.
08-01-2026
American Well Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007807, Size: 918 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. The core event is the entry into this unspecified Material Definitive Agreement. No transaction values, financial impacts, named entities, or other quantitative details are disclosed in the provided filing summary.
08-01-2026
Illumina, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001110803-26-000006, Size: 185 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.
08-01-2026
Praxis Precision Medicines, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001689548-26-000005, Size: 155 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event type is Officer Change from US SEC source. Sector not specified; no details on specific officer, position, reason, or nature of change provided.
08-01-2026
CONMED Corp filed an 8-K on 2026-01-08 (AccNo: 0001174947-26-000017, Size: 284 KB) disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer change, names, positions, reasons, or quantitative data provided.
08-01-2026
SS Innovations International, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002572, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
08-01-2026
Company filed an 8-K on 2026-01-08 (AccNo: 0001316944-26-000007, Size: 361 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event type is Officer Change, source us_sec, sector not specified. No specific details on officer name, position, appointment/resignation, reasons, or quantitative data provided.
08-01-2026
Janus International Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002199, Size: 918 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, or exhibits provided in the summary. Sector not specified.
08-01-2026
VolitionRx Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000107, size 737 KB), reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts disclosed in the provided summary. Sector not specified.
08-01-2026
Indaptus Therapeutics, Inc. filed an 8-K on 2026-01-08 (AccNo: 0001493152-26-001004, Size: 207 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data provided.
08-01-2026
Amphenol Corp (/DE/) filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002183, Size: 205 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, internal/external status, or quantitative data such as compensation are provided in the summary. Event type is Officer Change; sector not specified.
08-01-2026
FG Nexus Inc. disclosed the completion of an acquisition or disposition of assets in an 8-K filing on January 08, 2026 (AccNo: 0001493152-26-001002, Size: 250 KB) under Item 2.01. No details on parties involved, deal structure, valuation, or strategic rationale are provided in the filing summary. Sector is not specified.
08-01-2026
Wellgistics Health, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-001001, size: 940 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided information. Sector not specified.
08-01-2026
374Water Inc. filed an 8-K on January 8, 2026 (AccNo: 0001654954-26-000199, Size: 142 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, or any financial metrics are disclosed. Sector is not specified.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 84 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC